Clinical Services

New mRNA network to accelerate clinical translation

06 November, 2023

The network aims to advance mRNA medicine, foster scientific excellence in clinical translation and further the therapeutic potential of the mRNA platform.


Novel intervention to improve strength, mobility in rheumatoid arthritis

06 November, 2023

A novel exercise intervention being trialled by the University of South Australia researchers, in partnership with Arthritis SA, could help improve physical function and quality of life in people.


Sydney children's hospitals to receive positive pressure rooms

06 November, 2023

Using a specialised air ventilation system, these rooms function as a protective shield for some of the sickest and most vulnerable children.


Extreme weather injuries on the increase

03 November, 2023

New research shows that Australian hospital admissions for injuries resulting from extreme weather have increased — especially those relating to heat.


Alarming resistance rates prompt calls for updated antibiotic guidelines

01 November, 2023

Antibiotics to treat common infections in children and babies are no longer effective, due to high rates of resistance, reveals new research.


Getinge PICCO hemodynamic monitoring solution

01 November, 2023 | Supplied by: Getinge Australia Pty Ltd

Getinge's advanced hemodynamic monitoring solution PiCCO is designed to provide a minimally invasive measurement of cardiac output and its determinants (preload, afterload, contractility) as well as the quantification of pulmonary oedema through the measuring of the extravascular lung water index (ELWI).


Toolkit to guide health professionals on managing menopause

31 October, 2023

Monash University has led the development of a toolkit aimed at guiding health professionals around the world in assessing and treating women with menopausal health issues.


AF diagnosis linked to mild cognitive decline

31 October, 2023

Atrial fibrillation (AF) diagnosis was linked to a 45% increased risk of mild cognitive impairment (MCI) among a cohort of 4.3 million individuals in the UK.


Infectious diseases researcher recognised

30 October, 2023

UNSW infectious diseases researcher Dr Lise Lafferty has been recognised with the Paul Bourke Award for her approach to managing hepatitis C in prisons.


Hospital–university partnership increases access to rare cancer care

27 October, 2023

Access to personalised cancer treatments and the sharing of genetic testing information are among the aims of a new Monash Partners Comprehensive Cancer Consortium program.


Links between physical job risks and preterm birth: study

27 October, 2023

The Monash University-led study found that pregnant women were at significantly increased risk of preterm birth if they worked long hours or in shift work.


Study reveals barriers to accessing low-cost ketamine

25 October, 2023

Australian researchers have investigated why many patients with severe depression are unable to access potentially life-saving treatments.


Extra antibiotics to prevent joint replacement infections don't help: trial

23 October, 2023

A clinical trial has found that in joint replacement infection, the addition of vancomycin may lead to more infections and more adverse reactions for the patients.


Guillain-Barré syndrome risk six times higher after COVID-19: study

20 October, 2023

Having a COVID-19 infection is associated with an increased risk of developing Guillain-Barré syndrome within the next six weeks, according to a new study.


Trial for children with severe immune deficiency disorder

18 October, 2023

A potential cure for a severe immune deficiency disorder in children that makes them extremely vulnerable to infections will be offered in Australia under a gene therapy trial.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd